Skip to content

Depression: all studies

Page 497 of 1,034: studies 4,961 to 4,970 of 10,336, newest first. Back to the depression overview

Research

A deep learning approach for analyzing brainwave signals during audio meditation in expectant mothers: variational mode decomposition with a CNN-BiLSTM model.

Biomedical physics & engineering express March 31, 2026 Daisy Das, Nabamita Deb, Saswati Sanyal Choudhury

Meditation has increasingly been recognized as a helpful non-pharmacological intervention to treat psychological stress, anxiety, and depression during pregnancy-a period that plays a significant role in maternal and fetal health. Although very popular, there is very little scientific evidence on how brief audio meditation affects brain activity in pregnant women. This work reports an EEG-based...

Prefrontal cortical modulation during prostration (Sajdah): Neurophysiological Insights from a contemplative practice

Asian Journal of Medical Sciences March 31, 2026 Tahzeeb Fatima, Malik Tauseef, Shakib Shahab et al.

The prefrontal cortex is central to executive function, emotional regulation, and top-down control of limbic structures, particularly the amygdala. Dysregulation of prefrontal-limbic connectivity is implicated in anxiety, depression, and stress-related disorders. Contemplative practices enhance prefrontal regulation and reduce limbic reactivity, promoting emotional resilience. Prostration...

DOI: 10.71152/ajms.v17i4.5216 (opens in new tab) Contemplation Prefrontal cortex Neurophysiology Embodied cognition +6

Mystical Experience Induced by Esketamine Treatment: A Real-World Observational Study

medRxiv Preprint Server March 31, 2026 Maia Mallevays, Louise Fuet, Michel Danon et al. 1 citation preprint

Esketamine is a fast-acting antidepressant drug which induces acute psychoactive effects. The most frequent is a dissociative state which seems unrelated to therapeutic efficacy. Other esketamine-induced effects, including psychedelic-like mystical experiences, have been poorly studied in terms of phenomenology and frequency, and may carry specific therapeutic relevance. In this study, we...

Dissociative fugue following forced identity change in childhood: the first detailed case report from the Arab world

Middle East Current Psychiatry March 30, 2026 Mostafa Abulmagd, Syed Ali Bokhari, Muhanad Elnoor

Abstract Background To our knowledge, no detailed dissociative fugue cases have been reported from any Arab nation in the indexed literature, despite comprehensive searches across international databases and regional Arabic-language sources. Applied to the Arab world’s 492-million population, even conservative prevalence estimates suggest substantial numbers of undiagnosed cases, indicating...

Mitigating Psychological Distress in the Digital Age: Mindfulness as a Protective Factor among Female IT Professionals in Malaysia

International Journal of Academic Research in Business and Social Sciences March 30, 2026 Gahyatthri Pandian, Mohd Fakardian Che Rus

HRMARS - Workplace mental health challenges are increasingly prevalent in high-pressure industries, particularly within the information technology (IT) sector. Working women face compounded stressors due to professional demands and socio-cultural expectations, placing them at heightened risk of psychological distress. Mindfulness has been widely recognized as a protective factor that enhances...

Effectiveness of Mindfulness-Based Childbirth Parenting for Pregnant (MBCP) Interventions on Maternal Psychological Well-being: A Systematic Review

Journal of Pharmacy and Science March 30, 2026 Riska Adellia, I. Rachmawati, Titin Ungsianik et al.

Background: Pregnancy is a critical life stage characterized by physiological and psychosocial changes that increase vulnerability to mental health disorders such as depression, anxiety, and fear of childbirth. Objective: To identify Mindfulness-Based Childbirth and Parenting (MBCP) as an intervention for reducing depression, anxiety, stress, and fear of childbirth, as well as enhancing...

A Pilot Study of Loving-Kindness and Self-Compassion Meditation on Depressive Symptoms among People Living with HIV

Gadjah Mada Journal of Professional Psychology March 30, 2026 Martaria Rizky Rinaldi, Katrim Alifa Putrikita, Abdul Kholiq Ismail

Individuals living with HIV frequently experience elevated depressive symptoms due to chronic stress, stigma, and emotional burden. Compassion-based interventions such as Loving-Kindness and Self-Compassion Meditation (LKCM) have the potential to improve emotional well-being, yet evidence in HIV-positive populations remains limited. This study examined the preliminary effects of a brief...

DOI: 10.22146/gamajpp.113205 (opens in new tab) Meditation Depressive symptoms Depression economics Psychological intervention +4

“I can objectively view my trauma without feeling like I'm there”: Reddit discussions on self-reported use of psychedelics to address co-occurring substance use and mental health needs

Journal of Psychedelic Studies March 30, 2026 Emma Yuanqi Gu, Natalia M. Irvine, Megan Miller et al.

Abstract Introduction While the relationship between substance use disorders (SUD) and mental health conditions is well established, treatment for these co-occurring conditions is difficult to manage. Research on the potential for psychedelic treatments to address SUD and mental health conditions has recently seen a resurgence. This study aimed to explore narratives on the influence of...

DOI: 10.1556/2054.2026.00487 (opens in new tab) Addiction Mental health Context archaeology Exploratory research +8

Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders

Psychiatry and Clinical Psychopharmacology March 30, 2026 Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin

Major depressive disorder remains a leading cause of disability worldwide, and current antidepressants are limited by delayed onset and incomplete response. Building on advances driven by ketamine research, renewed interest has focused on classical serotonergic psychedelics—particularly psilocybin, N,N-dimethyltryptamine (DMT), 5-methoxy-DMT, and lysergic acid diethylamide (LSD)—which, under...

Unlocking 'stuckness' and catalysing change: A qualitative study of clinician and service leader perspectives on psychedelic-assisted therapy for substance use and mental health problems.

Addiction March 30, 2026 Sarah J Catchlove, Katrin Oliver, Michael Savic et al.

Australia recently down-scheduled and authorised psychedelic-assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness. While service leaders and clinicians are crucial to implementation, little research examines their...

DOI: 10.1111/add.70403 (opens in new tab) Full text (opens in new tab) Alcohol use disorders Health service design Implementation Integrated care +3